Last updated on February 2018

Serum Biomarkers Analysis in Patients With AR Treated With Anti-TMF

Brief description of study

Multicenter, prospective, observational study for evaluating if circulant rheumatoid factor, cyclic citrullinated anti-peptide anti-bodies and albumin can be used as potential predictors in the response to the treatment with anti-TNF in patients with rheumatoid arthritis after 24 weeks of treatment.

Clinical Study Identifier: NCT02804204

Contact Investigators or Research Sites near you

Start Over

Joan Maymó

Hospital de Bellvitge
L'Hospitalet de Llobregat, Spain
  Connect »

Sara Marsal, PhD

Hospital Vall d'Hebron
Barcelona, Spain
  Connect »

Hector Corominas

Hospital Moises Broggi
Sant Joan Despí, Spain
  Connect »